Physician profile
Allen Coopersmith
NPI 1538153978
$668.56
in general payments reported to CMS, 2019-2025
13 companies · $29.55 in 2025
The $29.55 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.17 · 2020: $12.33 · 2022: $249 · 2023: $98.76 · 2024: $265 · 2025: $29.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $186.02 | 2022-2023 | Aemcolo, Movantik, Talicia |
| Takeda Pharmaceuticals U.S.A., INC. | $94.63 | 2022-2024 | Entyvio, Eohilia |
| Abbvie INC. | $78.76 | 2023-2024 | Rinvoq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.97 | 2019-2024 | Xifaxan |
| Ardelyx, INC. | $55.07 | 2024-2025 | Ibsrela |
| Merck Sharp & Dohme LLC | $42.44 | 2024 | Dificid |
| Lilly USA, LLC | $34.45 | 2024 | Omvoh, Zepbound |
| Janssen Biotech, INC. | $25.64 | 2024 | Stelara |
| Braintree Laboratories, INC. | $19.68 | 2023 | Sutab |
| Mallinckrodt Hospital Products INC. | $16.91 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.59 | 2022 | |
| Qol Medical, LLC | $13.07 | 2022 | |
| Intercept Pharmaceuticals, INC. | $12.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Coopersmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.